Hemp THC regulation is inevitable, not a ban. Here’s how operators can prepare.

Joseph Sheehey (Courtesy photo)

(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)

Hemp-derived cannabinoids grew into a $28 billion market while operating in a gray area. This created opportunities, but also confusion and inconsistency – and, in some cases, risk for consumers.

One thing is certain: That phase is ending.

Though states are busy reviewing the way hemp-derived THC products including popular beverages are manufactured, marketed and sold, the most consequential event on the horizon is on the federal level.

On Nov. 12, hemp will be redefined under federal law, with a new total THC standard and strict limits on finished product cannabinoid content.

While some observers think a ban is inevitable, a likelier outcome is regulation. This is a call to action, not to alarm.

What is the future for hemp-derived THC in the US?

“Hemp” will be limited to cannabis products with no more than 0.3% total THC, including THCA. Finished products are capped at a maximum of 0.4 mg of THC per consumer container. Products exceeding those limits will no longer qualify as legal hemp at the federal level.

At the same time, states continue to take different approaches to hemp-derived cannabinoids. Meanwhile, a bipartisan proposal recently introduced in the Senate would allow states to opt out of portions of the upcoming federal framework.

Amid this serious uncertainty, operators in the space must prepare for a major industry disruption. This is not theoretical. Formulation, packaging, distribution, and retail availability across state lines will all be directly impacted.

Operators should already be reviewing product formulations, packaging structures, labeling, and distribution strategies. Companies that wait until enforcement begins to adapt may find themselves forced into rushed reformulations, discontinued SKUs or restricted market access across multiple states.

The future of hemp will depend on whether the industry can operate within clear standards around dosage, testing, labeling, and consumer safety.

What are the new federal Farm Bill standards for hemp THC?

The updated definition replaces the prior delta-9 THC-focused standard with a broader total THC calculation that includes multiple THC isomers and derivatives.

In practical terms, this means products that previously qualified as hemp under federal law may now be reclassified if total THC levels exceed the new threshold.

This includes:

• Delta-9 THC
• Delta-8 THC
• THCA (post-decarboxylation)
• Other THC isomers and analogs

One of the biggest challenges regulators face is how to define what is and is not acceptable when it comes to the amount of THC that can be sold, especially as current federal proposals move toward blanket caps that do not distinguish between low-dose and high-dose use cases.

Historically, this conversation has been overly simplistic, often focused on blanket limits that fail to reflect how these products are actually used.

Regulation should be based on dosage, not fear. A more effective approach is already available.

How much THC is too much?

Studies from Johns Hopkins have shown that THC’s effects are dose-dependent. Low doses produce no impairment compared with higher amounts. This underscores the need for regulatory frameworks that differentiate products by intended use and dosing.

Not all cannabinoid products are the same. A low-dose product designed to aid in stress management or sleep is fundamentally different from a high-dose product intended for intoxication.

Limits of 0.3% by weight or 0.4 milligrams by container puts both products in the same category and creates unnecessary restrictions and limits access for consumers who are not seeking a recreational high.

A dosage-based framework allows for both safety and access.

Without this distinction, upcoming federal changes risk treating a 2 milligram functional product the same as a high-dose intoxicating product, despite clear differences in consumer intent and physiological impact.

Hemp THC operators must also be responsible

If regulation is going to bring legitimacy to this space, it has to start with consistency and transparency.

That means age restrictions across the board for any product containing THC, even at low doses. It means child-resistant packaging that reflects the reality of where these products are used. And it means full supply chain transparency, backed by rigorous third-party testing.

The hemp industry has an opportunity to lead here.

In many ways, the current supplement market lacks the level of testing and accountability that consumers assume already exists. Hemp operators can set a higher standard, one that not only builds trust but also positions the category for long-term credibility.

Without these guardrails, bad actors will continue to cut corners, and the entire industry will carry the consequences.

Why the cannabis industry needs hemp THC

While the regulated marijuana and hemp industries have often been at odds, there’s an opportunity for cooperation here. That’s because despite THC’s growing acceptance, there is a segment of the population that will never walk into a dispensary.

That does not mean they are not interested in cannabinoid products. Far from it. Many of them are already using full-spectrum CBD with low-dose THC as part of their daily routines to manage stress, improve sleep, or support overall well-being.

For these consumers, accessibility is everything. This is already playing out at the state level. In Texas, lawmakers advanced a proposed hemp restriction that would have significantly limited access to hemp-derived cannabinoid products. While the measure has since been paused, it reflects a broader trend of states moving independently to restrict or reshape the market ahead of federal enforcement changes.

Texas is not an outlier. Multiple states are now moving to restrict or ban certain hemp-derived cannabinoids, creating a fragmented regulatory environment for operators.

Why hemp THC needs e-commerce

E-commerce has played a critical role in reaching this audience, providing a level of comfort, discretion, and simplicity that traditional retail environments often cannot. As regulation evolves, preserving a compliant path for direct-to-consumer access will be essential.

If that channel disappears, the industry does not just lose revenue. It loses an entire category of consumers who are looking for a different relationship with cannabis.

With the November 2026 deadline approaching and federal agencies preparing enforcement frameworks, the window for proactive adaptation is narrowing. Operators that employ transparent standards, dosage-based frameworks, and consumer-first access models will be the ones positioned to endure what comes next.

The businesses most likely to survive the transition will be the ones preparing now for a compliance-first market rather than relying on the regulatory ambiguity that defined the last several years.

A former NASA contributing aerospace engineer, Joseph Sheehey is the founder and CEO of Colorado-based cannabinoid wellness brand Cured Nutrition.